• Nextleaf (OILS) has announced audited financial results for fiscal 2022, which ended September 30, 2022
  • Revenue was $5,351,509, up by 52 per cent YoY
  • The company ended 2022 as a top 5 seller of CBD oil and a top 10 seller in vapes across B.C.
  • CEO Paul Pedersen sat down with Coreena Robertson to add context to the results and discuss what to expect from the company in the future
  • Nextleaf Solutions is a manufacturer and distributor of cannabis vapes and oils across Canada and internationally
  • Nextleaf (OILS) is down by 10 per cent trading at $0.045 per share

Nextleaf (OILS) has announced audited financial results for fiscal 2022, which ended September 30, 2022.

Select financial highlights

  • Revenue was $5,351,509, up by 52 per cent YoY
  • Cost of sales was $3,748,621, down by 12 per cent YoY
  • Gross profit came in at $661,238

Select operational highlights

  • The company ended 2022 as a top 5 seller of CBD oil and a top 10 seller in vapes across B.C.
  • It validated its technology to produce THC-free broad spectrum CBD distillate from industrial hemp feedstock. It launched its first THC-free CBD product subsequent to fiscal year end
  • It also became the first company in Canada to produce THC-O, which is not subject to excise tax

Subsequent to fiscal year end, Nextleaf entered the Newfoundland and Labrador market and completed its first international shipment of cannabis vape products.

CEO Paul Pedersen sat down with Coreena Robertson to add context to the results and discuss what to expect from the company in the future.

Nextleaf Solutions is a manufacturer and distributor of cannabis vapes and oils across Canada and internationally. Its flagship brand is the award-winning Glacial Gold.

Nextleaf (OILS) is down by 10 per cent trading at $0.045 per share as of 1:04 pm EST.


More From The Market Online
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: Who is making headlines this week?

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks
Rocket ship shooting from light bulb investment concept

The 5-Minute Investor Podcast, Ep. 13: A full breath of cannabis stocks

Welcome to episode 13 of The 5-Minute Investor Podcast, featuring Stockhouse columnists Jonathon Brown and Trevor Abes.
Cannabis leaves with Stock Talk and Cannabis Report labels

StockTalk | Cannabis Report: Say it, don’t spray it

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks
MediPharm Labs - MediPharm Labs Australia facility.

What is going on with MediPharm Labs?

MediPharm Labs (TSX:LABS) has begun production for its novel cannabis metered dose inhalers (MDIs) tailored for the EU and UK markets.